Research Topics
| Josep Maria HaroSummaryCountry: Spain Publications
| Collaborators
|
Detail Information
Publications
Treatment-seeking behavior of erectile dysfunction patients in Europe: Results of the Erectile Dysfunction Observational StudyJosep Maria Haro
Fundació Sant Joan de Déu, Esplugues de Llobregat, Spain
J Sex Med 3:530-40. 2006....
[Remission and relapse in the outpatient treatment of patients with schizophrenia. Outcomes at 3 years]J M Haro
Fundacion San Juan de Dios, Barcelona, Spain
Actas Esp Psiquiatr 36:187-96. 2008..Three year data collected in the frame of the SOHO study within Spain were used to evaluate antipsychotic treatment outcomes by analyzing remission and relapse as well as the factors influencing them...
Three-year antipsychotic effectiveness in the outpatient care of schizophrenia: observational versus randomized studies resultsJosep Maria Haro
San Joan de Déu Serveis de Salut Mental, Fundació Sant Joan de Déu, Dr Antoni Pujades, 42, 08830 Sant Boi de Llobregat, Barcelona, Spain
Eur Neuropsychopharmacol 17:235-44. 2007..Antipsychotic maintenance in SOHO was higher than the results of previous randomized studies...
Remission and relapse in the outpatient care of schizophrenia: three-year results from the Schizophrenia Outpatient Health Outcomes studyJosep Maria Haro
Sant Joan de Deu SSM, Fundació Sant Joan de Déu, Sant Boi de Llobregat, Barcelona, Spain
J Clin Psychopharmacol 26:571-8. 2006..The results should be interpreted conservatively because of the observational, nonrandomized study design...
Predictors of the course of illness in outpatients with schizophrenia: a prospective three year studyJ M Haro
Sant Joan de Deu SSM, Fundació Sant Joan de Déu, CIBER SAM, Spain
Prog Neuropsychopharmacol Biol Psychiatry 32:1287-92. 2008..The results show that description of the long-term outcome of schizophrenia cannot be summarized with just one outcome variable...
Antipsychotic treatment discontinuation in previously untreated patients with schizophrenia: 36-month results from the SOHO studyJosep Maria Haro
Sant Joan de Deu SSM, Fundació Sant Joan de Déu, CIBER Salud Mental Instituto de Salud Carlos III, Sant Boi de Llobregat, Barcelona, Spain
J Psychiatr Res 43:265-73. 2009..In conclusion, treatment effectiveness and tolerability varied among antipsychotic medications in previously untreated patients with schizophrenia. The results should be interpreted conservatively given the observational study design...
Evidence for three distinct classes of 'typical', 'psychotic' and 'dual' mania: results from the EMBLEM studyJ M Haro
Sant Joan de Deu SSM, Fundació Sant Joan de Déu, St Boi de Llobregat, Barcelona, Spain
Acta Psychiatr Scand 113:112-20. 2006..To describe patients included in the European Mania in Bipolar Longitudinal Evaluation of Medication (EMBLEM) study and to assess and clinically validate the presence of clinical subtypes of patients with acute mania...
2-Year course of bipolar disorder type I patients in outpatient care: factors associated with remission and functional recoveryJ M Haro
Parc Sanitari Sant Joan De Deu SSM, Centro de Investigación Biomédica en Red en Salud Mental CIBERSAM, Sant Boi de Llobregat, Barcelona, Spain
Eur Neuropsychopharmacol 21:287-93. 2011..In conclusion, functional recovery occurred in approximately half of those who achieved remission. Impairment of work and social functioning was consistently associated with lower remission and recovery rates...
Predictors of switching from mania to depression in a large observational study across Europe (EMBLEM)Eduard Vieta
Department of Psychiatry, Hospital Clinic, University of Barcelona IDIBAPS, CIBER SAM, Barcelona, Spain
J Affect Disord 118:118-23. 2009..Large observational studies may be useful in identifying variables that predict switch to depression after mania and provide data on medication use and outcomes in "real world" patients...
Impact of mental disorders and chronic physical conditions in health-related quality of life among primary care patients: results from an epidemiological studyAlejandra Pinto-Meza
Sant Joan de Deu SSM, Fundació Sant Joan de Déu, Barcelona, Spain
Qual Life Res 18:1011-8. 2009..To estimate the comorbidity of mental disorders with chronic physical conditions and to assess their independent and combined effects on health-related quality of life (HRQOL)...
Olanzapine monotherapy and olanzapine combination therapy in the treatment of mania: 12-week results from the European Mania in Bipolar Longitudinal Evaluation of Medication (EMBLEM) observational studyEduard Vieta
Bipolar Disorders Program, Hospital Clinic, University of Barcelona IDIBAPS, Barcelona, Spain
J Affect Disord 106:63-72. 2008....
Cross-national clinical and functional remission rates: Worldwide Schizophrenia Outpatient Health Outcomes (W-SOHO) studyJosep Maria Haro
Parc Sanitari Sant Joan de Deu, Fundació Sant Joan de Déu, CIBERSAM, Dr Antoni Pujadas, 42, 08830 Sant Boi de Llobregat, Barcelona, Spain
Br J Psychiatry 199:194-201. 2011..Evidence suggests that schizophrenia may have a better outcome for individuals living in low- and middle-income countries compared with affluent settings...
Gender differences in response to antipsychotic treatment in outpatients with schizophreniaJudith Usall
Sant Joan de Déu Serveis de Salut Mental, Fundació Sant Joan de Déu, Sant Boi de Llobregat, Barcelona, Spain
Psychiatry Res 153:225-31. 2007..In conclusion, in this group of outpatients with schizophrenia, gender is a predictor of clinical response to antipsychotic treatment, but its influence is not the same for all antipsychotics...
What is the relative importance of self reported psychotic symptoms in epidemiological studies? Results from the ESEMeD--Catalonia StudySusana Ochoa
Sant Joan de Déu Serveis de Salut Mental, Fundació Sant Joan de Déu, Dr Pujades, 42, Sant Boi de Llobregat, Barcelona, CIBERSAM Spain
Schizophr Res 102:261-9. 2008....
Effectiveness of olanzapine monotherapy and olanzapine combination treatment in the long term following acute mania--results of a two year observational study in bipolar disorder (EMBLEM)Ana Gonzalez-Pinto
International Mood Disorders Research Centre, Centro de Investigación Biomédica en Red en Salud Mental CIBERSAM, Hospital Santiago Apostol, University of the Basque Country, Vitoria, Spain
J Affect Disord 131:320-9. 2011..This study compared the 2-year outcomes of patients with a manic/mixed episode of bipolar disorder taking olanzapine monotherapy or olanzapine in combination with other agents...
Burden of chronic physical conditions and mental disorders in primary careAnna Fernandez
Sant Joan de Deu SSM, Fundació Sant Joan de Déu, Research and Development Unit, Dr Antoni Pujadas, 42, 08830 Sant Boi de Llobregat, Barcelona, Spain
Br J Psychiatry 196:302-9. 2010..The World Health Organization (WHO) has stated that the three leading causes of burden of disease in 2030 are projected to include HIV/AIDS, unipolar depression and ischaemic heart disease...
Why do clinicians maintain antidepressants in some patients with acute mania? Hints from the European Mania in Bipolar Longitudinal Evaluation of Medication (EMBLEM), a large naturalistic studyAdriane R Rosa
Bipolar Disorders Program, Hospital Clinic, University of Barcelona, CIBERSAM, Barcelona, Spain
J Clin Psychiatry 71:1000-6. 2010..Antidepressants are supposed to be withdrawn during a manic episode. The aim of this study was to analyze the characteristics of manic patients who received antidepressants during a manic phase in a large, naturalistic study...
Adequacy of antidepressant treatment in Spanish primary care: a naturalistic six-month follow-up studyAlejandra Pinto-Meza
Department of Research and Development, Sant Joan de Deu SSM, Carrer Dr Antoni Pujades, 42 Sant Boi de Llobregat, Barcelona, Spain
Psychiatr Serv 59:78-83. 2008..Factors that could be associated with adequacy of care also were explored...
Suicide ideation across reproductive life cycle of women. Results from a European epidemiological studyJudith Usall
Sant Joan de Deu SSM, Fundació Sant Joan de Déu, Instituto de Salud Carlos III, Centro de Investigación en Red de Salud Mental CIBERSAM, Spain
J Affect Disord 116:144-7. 2009..The aim of the present study is to compare suicide ideation among women in the pre-, peri-, and post-menopause using a cross-sectional household survey of non-institutionalised adults from six European countries...
Gender differences in outcomes of acute mania: a 12-month follow-up studyLaia Miquel
Sant Joan de Deu SSM, Fundació Sant Joan de Déu, Centro de Investigación Biomédica en Red de Salud Mental, Catalonia, Spain
Arch Womens Ment Health 14:107-13. 2011..Women had a faster time to mania improvement and a higher risk of developing a depressive episode during the 12-month follow-up period...
Obsessive-compulsive symptom dimensions in the general population: results from an epidemiological study in six European countriesM A Fullana
Anxiety Unit, IAPS, Hospital del Mar and Department of Psychiatry, Autonomous University of Barcelona, Barcelona, Spain
J Affect Disord 124:291-9. 2010..The prevalence of obsessive-compulsive symptom dimensions and their sociodemographic and psychopathological correlates at the population level are unknown...
[Prevalence and physical-mental comorbidity of chronic back and neck pain in Spain: results from the ESEMeD Study]Alejandra Pinto-Meza
, , Sant Boi de Llobregat, Barcelona,
Med Clin (Barc) 127:325-30. 2006..CONCLUSIONS: CBP-CNP is highly prevalent and comorbid with other physical and mental conditions. Comorbidity negatively affects individuals global functioning...
Do needs, symptoms or disability of outpatients with schizophrenia influence family burden?Susana Ochoa
Unitat de Recerca i Desenvolupament de Sant Joan de Déu SSM Research Unit CIBER SAM, C Pujades, 42, 08330, Sant Boi de Llobregat, Barcelona, Spain
Soc Psychiatry Psychiatr Epidemiol 43:612-8. 2008..This could cause high levels of family burden. The objective of this study is to assess the relationship between the patients' needs and other clinical and disability variables and the level of family burden...
Marginal structural models might overcome confounding when analyzing multiple treatment effects in observational studiesDavid Suarez
Research and Development Unit, Sant Joan de Deu SSM, Fundació Sant Joan de Déu, RETICS RD06 0011 REM TAP Network, Sant Boi, Barcelona, Spain
J Clin Epidemiol 61:525-30. 2008..Until now, MSMs have not been used to compare the effects of more than two treatments...
Rapid-cycling bipolar I disorder: course and treatment outcome of a large sample across EuropeN Cruz
Bipolar Disorders Program, Hospital Clinic, University of Barcelona, IDIBAPS, CIBER SAM, Barcelona, Spain
J Psychiatr Res 42:1068-75. 2008..To evaluate the baseline characteristics and follow-up outcomes of rapid-cycling (RC) bipolar I patients in a large, prospective, observational study...
Fluoxetine and imipramine: are there differences in cost-utility for depression in primary care?Antoni Serrano-Blanco
Sant Joan de Déu Serveis de Salut Mental, Fundació Sant Joan de Déu, Sant Boi de Ll, Barcelona, Spain
J Eval Clin Pract 15:195-203. 2009..Previous cost-utility studies, comparing selective serotonin reuptake inhibitors and tricyclic antidepressants, have used modelling techniques or have not included indirect costs in the economic analyses...
Adaptation and validation of the quality-of-life scale: Satisfaction with Life Domains Scale by Baker and IntagliataJanina Carlson
Research and Developmental Unit of Sant Joan de Déu SSM, Fundació Sant Joan de Déu, 08330 Sant Boi de Llobregat, Barcelona, Spain
Compr Psychiatry 50:76-80. 2009..There are few quality-of-life instruments specifically for schizophrenia; thus, the objective of our study is to adapt and validate the Satisfaction with Life Domains Scale (SLDS) by Baker and Intagliata...
Methodological aspects in the assessment of treatment effects in observational health outcomes studiesJosep Maria Haro
Research and Development Unit, RIRAG Network FIS G03 061, Sant Joan de Deu SSM, Fundació Sant Joan de Déu, Sant Boi, Barcelona, Spain
Appl Health Econ Health Policy 5:11-25. 2006..Observational studies, when properly conducted and when using adequate statistical methods, can provide valid information on the evaluation of health technologies...
Antipsychotic type and correlates of antipsychotic treatment discontinuation in the outpatient treatment of schizophreniaJosep Maria Haro
Research and Development Unit, Sant Joan de Déu Serveis de Salut Mental, Dr Antoni Pujades 42, 08030 Sant Boi, Barcelona, Spain
Eur Psychiatry 21:41-7. 2006..The findings from this study should be interpreted conservatively because of its non-randomized observational design...
Overview of the findings from the European SOHO studyDavid Suarez
Sant Joan de Déu Serveis de Salut Mental, Fundació Sant Joan de Déu, Barcelona, Spain
Expert Rev Neurother 8:873-80. 2008..The results from the SOHO study indicate that differences in effectiveness and tolerability do exist between the antipsychotics...
Reasons and outcomes of olanzapine dose adjustments in the outpatient treatment of schizophreniaD Suarez
Sant Joan de Deu SSM, Fundació Sant Joan de Déu, CIBER Salud Mental Instituto de Salud Carlos III, Sant Boi de Llobregat, Barcelona, Spain
Pharmacopsychiatry 42:135-40. 2009..Antipsychotic treatment dose adjustments may influence treatment outcomes in patients with schizophrenia...
Neurocognitive performance and negative symptoms: are they equal in explaining disability in schizophrenia outpatients?Victoria Villalta-Gil
Research and Development Unit, , , C/ Dr. Antoni Pujadas 42, 08830, St. Boi de Llobregat, Barcelona, Spain
Schizophr Res 87:246-53. 2006..The present findings suggest that further investigation on the mediators between clinical and social outcomes may help to design specific treatments to reduce disability...
The SOHO (Schizophrenia Outpatient Health Outcome) study: implications for the treatment of schizophreniaJosep Maria Haro
Sant Joan de Deu SSM, Fundació Sant Joan de Déu, Sant Boi de Llobregat, Barcelona, Spain
CNS Drugs 20:293-301. 2006..This important information is likely to impact on the future use of antipsychotics and will assist clinicians in refining the use of these drugs and improving the outcome of patients to whom they are prescribed...
Treatment adequacy of anxiety and depressive disorders: primary versus specialised care in SpainAnna Fernandez
Sant Joan de Deu SSM, Fundació Sant Joan de Déu, Sant Boi de Llobregat, Barcelona, Spain
J Affect Disord 96:9-20. 2006..This study aimed to describe the adequacy of treatment for Anxiety and Depressive disorders in Spain, how this differs between providers (primary versus specialised care) and which factors are associated with appropriate care...
Effectiveness of antipsychotic treatment for schizophrenia: 6-month results of the Pan-European Schizophrenia Outpatient Health Outcomes (SOHO) studyJ M Haro
Sant Joan de Déu Serveis de Salut Mental, Sant Boi, Barcelona, Spain
Acta Psychiatr Scand 111:220-31. 2005..To present the 6-month outcomes associated with antipsychotic treatment of patients participating in the Schizophrenia Outpatient Health Outcomes (SOHO) study...
The European Schizophrenia Outpatient Health Outcomes (SOHO) study: rationale, methods and recruitmentJ M Haro
Research and Development Unit, Sant Joan de Deu SSM, Sant Boi, Barcelona, Spain
Acta Psychiatr Scand 107:222-32. 2003..The role of observational studies in the assessment of the effectiveness of antipsychotic agents is reviewed, and the rationale, design and recruitment issues surrounding the SOHO study are presented...
The European Study of the Epidemiology of Mental Disorders (ESEMeD/MHEDEA 2000) project: rationale and methodsJ Alonso
Health Services Research Unit, Institut Municipal d Investigacio Medica IMIM IMAS, Barcelona, Spain
Int J Methods Psychiatr Res 11:55-67. 2002..The analysis of these differences should facilitate the monitoring of ongoing mental health reform initiatives in Europe and provide new research hypotheses...
Utilisation of mental health services and costs of patients with schizophrenia in three areas of SpainJ M Haro
Centro de Investigacíon en Minusvalías, Universidad de Cadiz, Spain
Br J Psychiatry 173:334-40. 1998....
Met and unmet needs of schizophrenia patients in a Spanish sampleS Ochoa
Unitat de Formació i Investigació, Sant Joan de Déu SMM, Sant Boi de Llobregat, Barcelona, Spain
Schizophr Bull 29:201-10. 2003..In a multiple regression model, needs were weakly associated with the clinical variables and quality of life. Needs assessment is complementary to clinical evaluation in schizophrenia...
Predictability of rehospitalization for schizophreniaJ M Haro
Department of Psychiatry, , Barcelona, Spain
Eur Arch Psychiatry Clin Neurosci 244:241-6. 1994..The results also show that the risk of rehospitalization depends on the previous tenures in the community...
Psychotropic prescribing in Catalonia: results from an epidemiological studyMaria Rubio-Valera
Research and Development Unit, Parc Sanitari Sant Joan de Deu, Fundació Sant Joan de Déu, Sant Boi de Llobregat, Barcelona, Spain
Fam Pract 29:154-62. 2012..Prescription of PSD is associated with clinical and non-clinical factors. Purpose. To describe the patterns of PSD prescribing over a 12-month period and to determine the factors associated with this in a PC population...
The transcription factor SP4 is reduced in postmortem cerebellum of bipolar disorder subjects: control by depolarization and lithiumRaquel Pinacho
Parc Sanitari Sant Joan de Deu, Fundació Sant Joan de Déu, Centro de Investigación Biomédica en Red de Salud Mental CIBERSAM, Barcelona, Spain
Bipolar Disord 13:474-85. 2011..We hypothesized that SP4 levels may be altered in the brain of bipolar disorder (BD) subjects and regulated by neuronal activity and drug treatment...
Gender differences in response to antidepressant treatment prescribed in primary care. Does menopause make a difference?Alejandra Pinto-Meza
Sant Joan de Deu SSM, Fundació Sant Joan de Déu, Spain
J Affect Disord 93:53-60. 2006....
Influence of gender on social outcome in schizophreniaJ Usall
Sant Joan de Deu, Serveis Salut Mental, Barcelona, Catalonia, Spain
Acta Psychiatr Scand 106:337-42. 2002..To study the relevance of gender on social functioning in schizophrenia...
Needs and its relation to symptom dimensions in a sample of outpatients with schizophreniaS Ochoa
Research and Development Unit, Sant Joan de Deu SSM, C Dr Pujades, 42, 08830 Sant Boi de Llobregat, Barcelona, Spain
Schizophr Res 75:129-34. 2005..To analyse the association between symptom dimensions in schizophrenia and number and type of met and unmet needs...
Association of perceived stigma and mood and anxiety disorders: results from the World Mental Health SurveysJ Alonso
Health Services Research Unit, Institut Municipal d Investigació Mèdica IMIM Hospital del Mar, Barcelona, Spain
Acta Psychiatr Scand 118:305-14. 2008..We assessed the prevalence of perceived stigma among persons with mental disorders and chronic physical conditions in an international study...
Validation in Spanish population of the family objective and subjective burden interview (ECFOS-II) for relatives of patients with schizophreniaM Vilaplana
Research and Development Unit, Fundación de Investigación, San Joan de Déu, Sant Boi de Llobregat, Barcelona, Spain
Actas Esp Psiquiatr 35:372-81. 2007..This paper aims to show the validity and reliability of the Spanish version of the Family Burden Interview Schedule (FBIS) designed to assess objective and subjective family burden for people with schizophrenia...
[One year prevalence of mental disorders comorbidity and associated socio-demographic risk factors in the general population of Spain. Results of the ESEMeD-Spain study]J Autonell
Sant Joan de Déu Serveis de Salut Mental, Fundació Sant Joan de Déu, Sant Boi de Llobregat, Barcelona
Actas Esp Psiquiatr 35:4-11. 2007..Comorbidity among mental disorders in the general population is common, affecting more than the 50 % of individuals with a lifetime mental disorder. In Spain, there are no data describing it or its associated risk factors...
Risk factors for suicidality in Europe: results from the ESEMED studyM Bernal
Sant Joan de Déu Serveis de Salut Mental, Fundació Sant Joan de Déu, Dr Antoni Pujades 42, 08830, Sant Boi de Llobregat, Spain
J Affect Disord 101:27-34. 2007..The aims of the present study were to investigate the prevalence and correlates of suicidal ideas and attempts in the general population of Europe...
[Epidemiology of mental disorders in Spain: methods and participation in the ESEMeD-Spain project]J M Haro
San Juan de Dios SSm Sant Boi de Llobregat, Barcelona, Spain
Actas Esp Psiquiatr 31:182-91. 2003....
Pharmacological treatment and other predictors of treatment outcomes in previously untreated patients with schizophrenia: results from the European Schizophrenia Outpatient Health Outcomes (SOHO) studyIsabelle Gasquet
INSERM U669, Maison des Adolescents, Hopital Cochin, AP HP, Paris, France
Int Clin Psychopharmacol 20:199-205. 2005..The results should be interpreted conservatively due to the observational study design...
Use of concomitant medication with antipsychotic treatment in outpatients with schizophrenia: results from the European Schizophrenia Outpatients Health Outcomes (SOHO) studyDiego Novick
Eli Lilly and Company, Windlesham, Surrey, UK
Prog Neuropsychopharmacol Biol Psychiatry 29:972-82. 2005..The results should be interpreted conservatively due to the observational design of SOHO...
Open-label olanzapine treatment in bipolar I disorder: clinical and work functional outcomesLizheng Shi
Department of Health Systems Management, Tulane University, New Orleans, LA, USA
Curr Med Res Opin 22:961-6. 2006..The objective of this study was to describe clinical and work functional outcomes associated with 6-month open-label olanzapine treatment for bipolar I disorder...
Clinical consequences of switching antipsychotic drugs in outpatients with schizophrenia: 36-month results from the European Schizophrenia Outpatient Health Outcomes studyDiego Novick
Eli Lilly and Company, Windlesham, Surrey, UK
Int Clin Psychopharmacol 23:203-8. 2008..Patients who switched to olanzapine experienced a higher weight gain. In conclusion, among patients switching antipsychotic medication, those who switched to olanzapine had better long-term outcomes...
Use of mental health services for anxiety, mood, and substance disorders in 17 countries in the WHO world mental health surveysPhilip S Wang
Division of Services and Intervention Research, National Institute of Mental Health, Rockville, MD, USA
Lancet 370:841-50. 2007..We describe mental health care in 17 countries participating in the WHO world mental health (WMH) survey initiative and examine unmet needs for treatment...
Symptomatic remission in previously untreated patients with schizophrenia: 2-year results from the SOHO studyDiego Novick
Eli Lilly and Company, Lilly Research Centre, Erl Wood Manor, Sunninghill Road, Windlesham, Surrey, GU20 6PH, UK
Psychopharmacology (Berl) 191:1015-22. 2007..Symptomatic remission is an achievable goal of treatment in patients with schizophrenia...
Clinical factors influencing the prescription of antidepressants and benzodiazepines: results from the European study of the epidemiology of mental disorders (ESEMeD)Koen Demyttenaere
Department of Psychiatry, University Hospital Gasthuisberg, Leuven, Belgium
J Affect Disord 110:84-93. 2008..To examine factors associated with the use of antidepressants (AD) and benzodiazepines (BZD) in 6 European countries...
The social, psychopathological and consumer context of rate of symptom improvement in acute maniaJim Van Os
Dept of Psychiatry and Neuropsychology, Maastricht University, European Graduate School of Neuroscience, PO Box 616, 6200, MD, Maastricht, The Netherlands
Soc Psychiatry Psychiatr Epidemiol 42:631-8. 2007..Knowledge of moderators of symptom improvement over time in acute mania improves predictability of individual patient outcomes. This study attempted to identify such moderators of the rate of symptom improvement...
Cost-utility analysis of treatment with olanzapine compared with other antipsychotic treatments in patients with schizophrenia in the pan-European SOHO studyMartin Knapp
Centre for the Economics of Mental Health, Institute of Psychiatry, London, UK
Pharmacoeconomics 26:341-58. 2008..To determine the cost utility of treating schizophrenic patients with olanzapine compared with other antipsychotics in a naturalistic outpatient setting...
Stability and treatment outcome of distinct classes of maniaInge van Rossum
Medical Department, Eli Lilly Nederland, Grootslag 1 5, Houten, The Netherlands
Eur Psychiatry 23:360-7. 2008..Differential treatment course and outcome after 12 weeks of treatment were examined for three distinct classes of patients with acute mania in bipolar disorder...
Methodological approach for assessing the cost-effectiveness of treatments using longitudinal observational data: the SOHO studyFrank Windmeijer
Department of Economics, University of Bristol, UK
Int J Technol Assess Health Care 22:460-8. 2006....
Sexual intercourse frequency in men presenting for treatment of erectile dysfunction: results from the pan-European erectile dysfunction observational studyAlan Riley
Lancashire School of Health and Postgraduate Medicine, University of Central Lancashire, Preston, United Kingdom
J Sex Marital Ther 33:3-18. 2007....
Therapeutic effectiveness and patient satisfaction after 6 months of treatment with tadalafil, sildenafil, and vardenafil: results from the erectile dysfunction observational study (EDOS)Antonio Martin-Morales
Hospital Carlos Haya, Servicio de Urologia, Malaga, Spain
Eur Urol 51:541-50; discussion 550. 2007..This observational study was conducted across Europe to assess health outcomes in men with erectile dysfunction (ED) who took tadalafil, sildenafil citrate (sildenafil), or vardenafil HCl (vardenafil) for 6 mo...
Mental disorders among persons with heart disease - results from World Mental Health surveysJohan Ormel
Department of Psychiatry, University Medical Center Groningen, University of Groningen, 9700 RB Groningen, The Netherlands
Gen Hosp Psychiatry 29:325-34. 2007..Consistency across emotional disorders and cultures would suggest that relatively universal mechanisms underlie the association...
Assessment of remission in schizophrenia with the CGI and CGI-SCH scalesJosep Maria Haro
Acta Psychiatr Scand 117:156. 2008
[Prevalence and risk factors for suicide ideation, plans and attempts in the Spanish general population. Results from the ESEMeD study]Andrea Gabilondo
Unidad de Investigación en Servicios Sanitarios, Institut Municipal d Investigacio Medica, Barcelona, Espana
Med Clin (Barc) 129:494-500. 2007..Suicide is a public health problem and it is increasing in Spain. The objective of this study is to analyze the prevalence and risk factors of suicide related outcomes (ideation, plan and attempt) using data from the ESEMeD-Spain project...
Mental disorders among persons with chronic back or neck pain: results from the World Mental Health SurveysKoen Demyttenaere
Department of Neurosciences and Psychiatry, University Hospital Gasthuisberg, Herestraat 49, B 3000 Leuven, Belgium
Pain 129:332-42. 2007..The association of mental disorders with back/neck pain showed a consistent pattern across both developed and developing countries...
Concordance of the Composite International Diagnostic Interview Version 3.0 (CIDI 3.0) with standardized clinical assessments in the WHO World Mental Health surveysJosep Maria Haro
Int J Methods Psychiatr Res 15:167-80. 2006..The validity of the CIDI is likely to be under-estimated in these comparisons due to the fact that the reliability of the SCID diagnoses, which is presumably less than perfect, sets a ceiling on maximum CIDI-SCID concordance...
Prevalence, severity, and unmet need for treatment of mental disorders in the World Health Organization World Mental Health SurveysKoen Demyttenaere
JAMA 291:2581-90. 2004..Structural barriers exist to this reallocation. Careful consideration needs to be given to the value of treating some mild cases, especially those at risk for progressing to more serious disorders...
Differences in lifetime use of services for mental health problems in six European countriesViviane Kovess-Masfety
Mutuelle Générale de l Education Nationale MGEN Foundation for Public Health, EA 4069, University of Paris 5, Paris, France
Psychiatr Serv 58:213-20. 2007....
